GRNA — Greenlight Biosciences Holdings PBC Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $45.43m
- $37.72m
- $6.78m
Annual balance sheet for Greenlight Biosciences Holdings PBC, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 25.9 | 95.1 | 31.4 | 68.1 |
| Prepaid Expenses | ||||
| Total Current Assets | 26.5 | 97.1 | 33.8 | 71.3 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 3.75 | 16.3 | 23.4 | 74.1 |
| Other Long Term Assets | ||||
| Total Assets | 30.6 | 114 | 63.1 | 149 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 5.72 | 13.9 | 62.3 | 35.6 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 6.95 | 33.9 | 93 | 101 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 23.7 | 80 | -30 | 48.1 |
| Total Liabilities & Shareholders' Equity | 30.6 | 114 | 63.1 | 149 |
| Total Common Shares Outstanding |